Palomo-Piñón S

Idioma: Inglés [English version]
Referencias bibliográficas: 13
Paginas: s40-42
Archivo PDF: 164.33 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Correa-Rotter R, Méndez Durán A, Vallejos A, Rico-Fontalvo J, Cusumano AM, Rosa-Diez GJ et al. Unmet needs of CKD in Latin America: a review from expert virtual working group. Kidney Int Rep. 2023; 8: 954-996. doi: 10.1016/j.ekir.2023.02.1082.

2. Detección, diagnóstico y tratamiento de Enfermedades Hipertensivas del Embarazo. Guía de Evidencias y Recomendaciones: Guía de Práctica Clínica. México: IMSS; 2017.

3. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018; 72 (1): 24-43.

4. Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb D et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010; 28: 826-833. doi: 10.1097/HJH.0b013e328335c29a.

5. Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020; 75 (18): 2323-2334. doi: 10.1016/j.jacc.2020.03.028.

6. Palomo-Piñón S, Antonio-Villa NE, García-Cortés LR, Álvarez-Aguilar C, González-Palomo E, Bertadillo-Mendoza OM et al. Prevalence and characterization of undiagnosed arterial hypertension in the eastern zone of Mexico. J Clin Hypertens (Greenwich). 2022; 24 (2): 131-139. doi: 10.1111/jch.14414.

7. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019; 105: 1273-1278. doi: 10.1136/heartjnl-2018-313453.

8. Oslo G, Bernstein I. Preeclampsia and maternal cardiovascular disease: consequence or predisposition? J Vasc Res. 2014; 51: 290-304.

9. Malek AM, Hunt KJ, Turan TN, Mateus J, Lackland DT, Lucas A et al. Hypertensive disorders of pregnancy with and without pre-pregnancy hypertension are associated with incident maternal kidney disease subsequent to delivery. Hypertension. 2022; 79: 844-854. doi: 10.1161/HYPERTENSIONAHA.121.18451.

10. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008; 359: 800-809. doi: 10.1056/NEJMoa0706790.

11. Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014; 210: 147.e1-147.e8. doi: 10.1016/j.ajog.2013.09.027.

12. Ishaku SM, Olanrewaju TO, Browne JL, Klipstein-Grobusch K, Kayode GA, Franx A et al. Prevalence and determinants of chronic kidney disease in women with hypertensive disorders in pregnancy in Nigeria: a cohort study. BMC Nephrol. 2021; 22: 229. doi: 10.1186/s12882-021-02419-6.

13. Sandvik MK, Hallan S, Svarstad E, Vikse BE. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol. 2013; 8: 1126-1134.